An observational, prospective cohort study to evaluate the long-term safety and efficacy of infliximab SC in patients with Ankylosing spondylitis, Rheumatoid arthritis in Korea

Chonnam National University Bitgoeul Hospital0 个研究点目标入组 1,412 人开始时间: 待定最近更新: 2024年4月2日

适应症

试验速览

暂无简介。

•1) Patients who can administer Infliximab SC (subcutaneous injection) under approved indication of this drug
•2) an adult patient over the age of 19
•3) Those who voluntarily agreed in writing to this study
•4) Among women of childbearing age, appropriate contraception is performed to prevent pregnancy and Infliximab SC
•5) Those who can use contraception for at least six months after the final dose (the implementation of contraception is based on risks and benefits)
•It can be decided after discussion with a female researcher.)
•5) Voluntarily for long-term follow-up, including access to all medical records
•Patient by (signed ICF)

•1) A person who is prohibited from being administered as specified in the product description of this drug
•2) A person who intends to use Infliximab SC for purposes other than permission
•3) a pregnant woman or nursing woman
•4) Patients who are unfit to participate in research by researcher's judgment

发起方

Chonnam National University Bitgoeul Hospital